# Phase 2 stroke trials recruiting: 80 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 80 trials in phase 2 for stroke that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 stroke trials: 80 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/stroke

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 80
- Recruiting or not yet: 80
- Read on: November 19, 2026

## Trials

The 25 newest of 80, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07938203 | MitoQ Supplementation for Microvascular Health and Stroke Recovery | Medical College of Wisconsin | Phase 2 | Not yet recruiting | Stroke, Stroke Recurrence | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938203) |
| November 3, 2026 | NCT07914647 | Remote Ischaemic Conditioning for Fatigue After Stroke 2 (RICFAST 2) | Sheffield Teaching Hospitals NHS Foundation Trust | Phase 2 | Recruiting | Stroke, Fatigue | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914647) |
| October 22, 2026 | NCT07890298 | A Study to Evaluate the Intracranial Arterial Recanalization With Multiple Doses of LT3001 Drug Product in AIS Participant | Lumosa Therapeutics Co., Ltd. | Phase 2 | Recruiting | Acute Ischemic Stroke | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890298) |
| September 28, 2026 | NCT07844603 | Combined Antiplatelet Strategy in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPRIME) | University of Alberta | Phase 2 | Not yet recruiting | Acute Ischemic Stroke | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07844603) |
| September 24, 2026 | NCT07839936 | A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease | Eli Lilly and Company | Phase 2 | Recruiting | Atherosclerosis, Cardiovascular Disease, Hypercholesterolemia | 175 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839936) |
| September 2, 2026 | NCT07800572 | Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2) | Capital Medical University | Phase 2 | Recruiting | Acute Ischemic Stroke | 204 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07800572) |
| September 1, 2026 | NCT07798401 | Digital Intelligent Tongue-Pressure Biofeedback Resistance Training for Post-Stroke Dysphagia: A Randomized Controlled Trial | First People's Hospital of Foshan | Phase 2 | Recruiting | Dysphagia, Stroke | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07798401) |
| August 10, 2026 | NCT07754825 | A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke | Shanghai Pharmaceuticals Holding Co., Ltd | Phase 2 | Not yet recruiting | Acute Ischemic Stroke | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07754825) |
| August 3, 2026 | NCT07742098 | A Phase 2a Study to Evaluate the Dose-response, Safety, Tolerability, Efficacy, and Population Pharmacokinetics of Intravenous NTS-521... | NeuroTrauma Sciences, LLC | Phase 2 | Not yet recruiting | Acute Ischemic Stroke | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07742098) |
| July 31, 2026 | NCT07739160 | The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients | Beijing Suncadia Pharmaceuticals Co., Ltd | Phase 2 | Recruiting | Acute Ischemic Stroke | 340 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07739160) |
| July 17, 2026 | NCT07709845 | CC-101 (f/k/a NR1) Neural Stem Cell Transplantation for Adults With Chronic Ischemic Stroke | Clarion Cells, Inc. | Phase 2 | Not yet recruiting | Chronic Ischemic Stroke | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07709845) |
| July 15, 2026 | NCT07704840 | A Pilot Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants With Post-Stroke... | Sponsor not shown (see the record) | Phase 2 | Recruiting | Post-Stroke Spasticity | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704840) |
| June 16, 2026 | NCT07651332 | A Study of Probiotics in Patients With Acute Ischemic Stroke | Capital Medical University | Phase 2 | Not yet recruiting | Ischemic Stroke | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07651332) |
| June 12, 2026 | NCT07646522 | Telerehabilitation and Biomarkers of Recovery After Stroke in Brazil | University of Sao Paulo | Phase 2 | Recruiting | Stroke | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07646522) |
| June 12, 2026 | NCT07645560 | A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke | Beijing Tiantan Hospital | Phase 2 | Not yet recruiting | Ischemic Stroke | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07645560) |
| May 12, 2026 | NCT07581210 | Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular Thrombectomy | Shanghai QuietD Biotechnology Co., Ltd. | Phase 2 | Recruiting | Acute Ischemic Stroke | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07581210) |
| April 24, 2026 | NCT07550296 | Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With... | General Hospital of Shenyang Military Region | Phase 2 | Recruiting | Acute Ischemic Stroke | 122 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07550296) |
| April 8, 2026 | NCT07516522 | Intra-arterial Methylprednisolone After Endovascular Thrombectomy | Tang-Du Hospital | Phase 2 | Recruiting | Ischemia Stroke, Thrombectomy, Large Vessel Occlusion | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07516522) |
| April 6, 2026 | NCT07511543 | Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy | Population Health Research Institute | Phase 2 | Not yet recruiting | Ischemic Stroke | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07511543) |
| March 30, 2026 | NCT07501533 | Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke | First Affiliated Hospital of Wannan Medical College | Phase 2 | Recruiting | Severe Stroke | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07501533) |
| February 24, 2026 | NCT07430917 | Safety and Efficacy of J147 in Acute Ischemic Stroke | Abrexa Pharmaceuticals, Inc. | Phase 2 | Recruiting | Acute Ischemic Stroke | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07430917) |
| February 20, 2026 | NCT07423975 | Advancing Reperfusion Therapy for Ischemic Stroke: Safety and Efficacy of Anakinra for Futile Reperfusion Following Endovascular Treatment... | Beijing Tiantan Hospital | Phase 2 | Recruiting | Stroke Acute, Endovascular Treatment | 159 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07423975) |
| February 17, 2026 | NCT07415655 | Modulation of Cerebral Ischemia by Albumin | University Hospital Hradec Kralove | Phase 2 | Recruiting | Ischemic Stroke | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07415655) |
| February 12, 2026 | NCT07406971 | Safety of Transmucosal Capsaicin Sphenopalatine Ganglion Stimulation in Acute Ischemic Stroke | Instituto Mexicano del Seguro Social | Phase 2 | Recruiting | Ischemic Stroke | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07406971) |
| February 9, 2026 | NCT07397923 | Exploratory Evaluation of the Digital Therapeutic Device Zenicom for Subacute Stroke Aphasia | Seoul National University Bundang Hospital | Phase 2 | Recruiting | Aphasia, Stroke | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07397923) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Pennsylvania | 4 |
| Beijing Tiantan Hospital | 4 |
| General Hospital of Shenyang Military Region | 4 |
| Johns Hopkins University | 2 |
| Capital Medical University | 2 |
| [Shanghai Pharmaceuticals Holding Co., Ltd](https://specstream.ai/data/clinical-trials/company/shanghai-pharmaceuticals-holding-co-ltd) | 2 |
| Chang Gung Memorial Hospital | 2 |
| Medical College of Wisconsin | 2 |
| Tianjin Huanhu Hospital | 2 |
| University of Pittsburgh | 2 |
| University Hospital Hradec Kralove | 1 |
| First People's Hospital of Foshan | 1 |
| Population Health Research Institute | 1 |
| NeuroTrauma Sciences, LLC | 1 |
| Duke University | 1 |
| University of Illinois at Urbana-Champaign | 1 |
| Spaulding Rehabilitation Hospital | 1 |
| [Beijing Suncadia Pharmaceuticals Co., Ltd](https://specstream.ai/data/clinical-trials/company/beijing-suncadia-pharmaceuticals-co-ltd) | 1 |
| Universidade Federal de Pernambuco | 1 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 1 |
| Changzhou Qianhong Bio-pharma Co., Ltd. | 1 |
| University Hospital, Lille | 1 |
| ThromBio Pty. Ltd. | 1 |
| University of Sao Paulo | 1 |
| Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 25 |
| China | 23 |
| Canada | 5 |
| Brazil | 4 |
| France | 4 |
| United Kingdom | 3 |
| Australia | 3 |
| Belgium | 2 |
| Germany | 2 |
| Japan | 2 |
| Taiwan | 2 |
| Czechia | 1 |
| Greece | 1 |
| India | 1 |
| Italy | 1 |
| Denmark | 1 |
| South Korea | 1 |
| Switzerland | 1 |
| Argentina | 1 |
| Mexico | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Carpet installation companies in the United States](https://specstream.ai/data/businesses/carpet-installation-companies/united-states)
- [Financial services firms in the United States](https://specstream.ai/data/businesses/financial-services-firms/united-states)
- [Livestock feed and supply stores in the United States](https://specstream.ai/data/businesses/livestock-feed-and-supply-stores/united-states)
- [Psychiatry practices in the United States](https://specstream.ai/data/businesses/psychiatry-practices/united-states)
- [Vehicle manufacturers in the United States](https://specstream.ai/data/businesses/vehicle-manufacturers/united-states)
- [Blinds and shades companies in the United States](https://specstream.ai/data/businesses/blinds-and-shades-companies/united-states)
